Business Description
MAIA Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : US5526411021
Description
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -0.66 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -31.8 | |||||
3-Year EPS without NRI Growth Rate | -33.8 | |||||
3-Year FCF Growth Rate | -78.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.76 | |||||
9-Day RSI | 45.83 | |||||
14-Day RSI | 47.63 | |||||
6-1 Month Momentum % | 343.48 | |||||
12-1 Month Momentum % | 135.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.77 | |||||
Quick Ratio | 1.77 | |||||
Cash Ratio | 1.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.9 | |||||
Shareholder Yield % | -14.51 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1259.5 | |||||
ROA % | -278.27 | |||||
ROIC % | -1295.67 | |||||
ROCE % | -549.3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.11 | |||||
EV-to-Forward-EBIT | -2.56 | |||||
EV-to-EBITDA | -3.11 | |||||
EV-to-Forward-EBITDA | -2.5 | |||||
EV-to-FCF | -5.55 | |||||
Earnings Yield (Greenblatt) % | -32.15 | |||||
FCF Yield % | -17.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:MAIA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MAIA Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.58 | ||
Beta | 0 | ||
Volatility % | 124.93 | ||
14-Day RSI | 47.63 | ||
14-Day ATR ($) | 0.391529 | ||
20-Day SMA ($) | 3.519 | ||
12-1 Month Momentum % | 135.02 | ||
52-Week Range ($) | 0.82 - 5.99 | ||
Shares Outstanding (Mil) | 21.84 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MAIA Biotechnology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MAIA Biotechnology Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MAIA Biotechnology Inc Frequently Asked Questions
What is MAIA Biotechnology Inc(MAIA)'s stock price today?
The current price of MAIA is $3.39. The 52 week high of MAIA is $5.99 and 52 week low is $0.82.
When is next earnings date of MAIA Biotechnology Inc(MAIA)?
The next earnings date of MAIA Biotechnology Inc(MAIA) is 2024-08-30 Est..
Does MAIA Biotechnology Inc(MAIA) pay dividends? If so, how much?
MAIA Biotechnology Inc(MAIA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |